Cancer Pathology, Molecular Diagnostics & Biomarkers

Accurate diagnosis and molecular characterization are fundamental to modern cancer management. This session explores developments in pathology, molecular diagnostics, biomarker discovery, liquid biopsy, minimal residual disease detection, and laboratory technologies that support cancer classification, prognosis, monitoring, and therapeutic decision-making.

Abstract Scope and Participation

Abstracts may cover histopathology, molecular pathology, cancer biomarkers, companion diagnostics, liquid biopsy, circulating tumor DNA, minimal residual disease, molecular testing, diagnostic platforms, and emerging laboratory methods. Pathologists, laboratory scientists, oncologists, molecular biologists, diagnostic researchers, and industry professionals are welcome.